TACT vs. QMCO, LTRX, SILC, ALOT, INVE, OSS, MKFG, ZEPP, LINK, and FOXX
Should you be buying TransAct Technologies stock or one of its competitors? The main competitors of TransAct Technologies include Quantum (QMCO), Lantronix (LTRX), Silicom (SILC), AstroNova (ALOT), Identiv (INVE), One Stop Systems (OSS), Markforged (MKFG), Zepp Health (ZEPP), Interlink Electronics (LINK), and Foxx Development (FOXX). These companies are all part of the "computer hardware" industry.
TransAct Technologies vs.
TransAct Technologies (NASDAQ:TACT) and Quantum (NASDAQ:QMCO) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.
74.5% of TransAct Technologies shares are owned by institutional investors. Comparatively, 63.7% of Quantum shares are owned by institutional investors. 15.5% of TransAct Technologies shares are owned by insiders. Comparatively, 3.9% of Quantum shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Quantum had 4 more articles in the media than TransAct Technologies. MarketBeat recorded 6 mentions for Quantum and 2 mentions for TransAct Technologies. Quantum's average media sentiment score of 0.86 beat TransAct Technologies' score of 0.00 indicating that Quantum is being referred to more favorably in the news media.
TransAct Technologies has higher earnings, but lower revenue than Quantum.
TransAct Technologies has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Comparatively, Quantum has a beta of 3.07, meaning that its share price is 207% more volatile than the S&P 500.
Quantum has a net margin of 0.00% compared to TransAct Technologies' net margin of -4.24%. Quantum's return on equity of 0.00% beat TransAct Technologies' return on equity.
TransAct Technologies received 297 more outperform votes than Quantum when rated by MarketBeat users. Likewise, 61.20% of users gave TransAct Technologies an outperform vote while only 27.27% of users gave Quantum an outperform vote.
TransAct Technologies presently has a consensus target price of $7.50, indicating a potential upside of 99.47%. Quantum has a consensus target price of $19.00, indicating a potential upside of 17.14%. Given TransAct Technologies' stronger consensus rating and higher possible upside, analysts clearly believe TransAct Technologies is more favorable than Quantum.
Summary
TransAct Technologies beats Quantum on 9 of the 16 factors compared between the two stocks.
Get TransAct Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for TACT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TransAct Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:TACT) was last updated on 3/25/2025 by MarketBeat.com Staff
